The Cancer Center has entered a dynamic growth phase with the recruitment of 35 faculty in the past four years. During this period, the Cancer Center has provided significant resources (space and/or financial) for the recruitment of nineteen faculty. CCSG developmental funds were used to support nine of these faculty. Each of the nine faculty recruited with CCSG developmental funds has peer-reviewed funding amounting to $11.28 million (total direct costs). In 2003, the Chancellor of UNMC has given the Cancer Center an additional 43,000 sq. ft. of research space to continue its growth and development over the next five years. In 2002, the state of Nebraska enacted legislation, the Nebraska Tobacco Settlement Funds for Biomedical Research, which will provide significant resources (at least $4.8 million annually) to the University of Nebraska Medical Center for recruitment. Over the next five years, the Cancer Center plans to recruit new faculty in the Eppley Institute for Cancer Research as well as in basic, clinical and population science departments at UNMC. Over the next five years the Cancer Center plans to recruit at least 12 additional faculty in basic cancer research, 5-7 new faculty in clinical/translational research, and at least three additional faculty in cancer epidemiology, control, and prevention. CCSG Developmental funds will be used to support the recruitment of new Cancer Center faculty. The Cancer Center also utilizes resources from the state of Nebraska (including LB595, LB506, and the Nebraska Research Initiative) and philanthropy to provide support for recruitment, pilot projects, and enhancements of shared resources.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA036727-22
Application #
7287322
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2006-08-01
Budget End
2007-07-31
Support Year
22
Fiscal Year
2006
Total Cost
$184,753
Indirect Cost
Name
University of Nebraska Medical Center
Department
Type
DUNS #
168559177
City
Omaha
State
NE
Country
United States
Zip Code
68198
Neilsen, Beth K; Chakraborty, Binita; McCall, Jamie L et al. (2018) WDR5 supports colon cancer cells by promoting methylation of H3K4 and suppressing DNA damage. BMC Cancer 18:673
Schopfer, Lawrence M; Lockridge, Oksana (2018) Chlorpyrifos oxon promotes tubulin aggregation via isopeptide cross-linking between diethoxyphospho-Lys and Glu or Asp: Implications for neurotoxicity. J Biol Chem 293:13566-13577
Baranovskiy, Andrey G; Duong, Vincent N; Babayeva, Nigar D et al. (2018) Activity and fidelity of human DNA polymerase ? depend on primer structure. J Biol Chem 293:6824-6843
Khadge, Saraswoti; Sharp, John Graham; Thiele, Geoffrey M et al. (2018) Dietary omega-3 and omega-6 polyunsaturated fatty acids modulate hepatic pathology. J Nutr Biochem 52:92-102
Kuss, Mitchell; Kim, Jiyoung; Qi, Dianjun et al. (2018) Effects of tunable, 3D-bioprinted hydrogels on human brown adipocyte behavior and metabolic function. Acta Biomater 71:486-495
Ingersoll, Matthew A; Chou, Yu-Wei; Lin, Jamie S et al. (2018) p66Shc regulates migration of castration-resistant prostate cancer cells. Cell Signal 46:1-14
Svechkarev, Denis; Kyrychenko, Alexander; Payne, William M et al. (2018) Development of colloidally stable carbazole-based fluorescent nanoaggregates. J Photochem Photobiol A Chem 352:55-64
Ambardekar, Vishakha V; Wakaskar, Rajesh R; Ye, Zhen et al. (2018) Complexation of Chol-DsiRNA in place of Chol-siRNA greatly increases the duration of mRNA suppression by polyplexes of PLL(30)-PEG(5K) in primary murine syngeneic breast tumors after i.v. administration. Int J Pharm 543:130-138
Tian, Tian; Bi, Chengfeng; Hein, Ashley L et al. (2018) Rac1 is a novel therapeutic target in mantle cell lymphoma. Blood Cancer J 8:17
Saxena, Sugandha; Purohit, Abhilasha; Varney, Michelle L et al. (2018) Semaphorin-5A maintains epithelial phenotype of malignant pancreatic cancer cells. BMC Cancer 18:1283

Showing the most recent 10 out of 1372 publications